Tom Goodrich

Tom Goodrich is a Co-Founder and General Partner at Corner Ventures, a Palo Alto-based venture capital firm spun out of DAG Ventures in 2018. With more than three decades of investing and private equity experience, Goodrich leads Corner's biotech investment portfolio - including notable exits like Armo Biosciences (acquired by Eli Lilly) and Arresto Biosciences (acquired by Gilead Sciences). Before Corner Ventures, he co-founded DAG Ventures in 2004 and Duff Ackerman & Goodrich in 1991, and earlier in his career worked at Bechtel Investments, served as a consultant to Bank of America's chairman, and helped build Dimensional Corporate Finance with backing from Xerox. He holds an A.B. from Dartmouth College and an MBA from Stanford Graduate School of Business.